Gentian Diagnostics ASA
OSE:GENT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gentian Diagnostics ASA
OSE:GENT
|
NO |
|
S
|
SuNam Co Ltd
KOSDAQ:294630
|
KR |
|
F
|
Fine Metal Technologies PCL
SET:FMT
|
TH |
|
Roots Corp
TSX:ROOT
|
CA |
|
EdiliziAcrobatica SpA
MIL:EDAC
|
IT |
|
DarioHealth Corp
NASDAQ:DRIO
|
US |
|
J B Hunt Transport Services Inc
NASDAQ:JBHT
|
US |
|
A
|
ALBA SE
XHAM:ABA
|
DE |
|
M
|
Maritime Launch Services Inc
NEO:MAXQ
|
CA |
|
Comcast Corp
NASDAQ:CMCSA
|
US |
|
Pantera Minerals Ltd
ASX:PFE
|
AU |
|
T
|
Telemedycyna Polska SA
WSE:TMP
|
PL |
|
Q
|
Quarticon SA
WSE:QON
|
PL |
|
N
|
National Health Scan
OTC:GEGR
|
US |
|
N
|
Nebius Group NV
DUS:YDX
|
NL |
|
S
|
Skin Elements Ltd
ASX:SKN
|
AU |
|
R
|
Recordati Industria Chimica e Farmaceutica SpA
F:RER1
|
IT |
|
Urbas Grupo Financiero SA
F:UZY
|
ES |
|
Spacetalk Ltd
ASX:SPA
|
AU |
|
GeoVax Labs Inc
NASDAQ:GOVX
|
US |
|
Hong Kong Exchanges and Clearing Ltd
HKEX:388
|
HK |
|
Ameren Corp
NYSE:AEE
|
US |
|
I
|
Interactive Health Network
OTC:IGRW
|
US |
|
Ramky Infrastructure Ltd
NSE:RAMKY
|
IN |
Wall St Price Targets
GENT Price Targets Summary
Gentian Diagnostics ASA
According to Wall Street analysts, the average 1-year price target for GENT is 61.2 NOK with a low forecast of 60.6 NOK and a high forecast of 63 NOK.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GENT's stock price target?
Price Target
61.2
NOK
According to Wall Street analysts, the average 1-year price target for GENT is 61.2 NOK with a low forecast of 60.6 NOK and a high forecast of 63 NOK.
What is the Revenue forecast for Gentian Diagnostics ASA?
Projected CAGR
15%
Over the last 9 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 15%.
What is the Gross Profit forecast for Gentian Diagnostics ASA?
Projected CAGR
19%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 22%. The projected CAGR for the next 3 years is 19%.
What is the Operating Income forecast for Gentian Diagnostics ASA?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 3 years is 31%.
What is the Pre-Tax Income forecast for Gentian Diagnostics ASA?
Projected CAGR
53%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 53%.
What is the Net Income forecast for Gentian Diagnostics ASA?
Projected CAGR
56%
The compound annual growth rate for Net Income over the next 3 years is 56%.